awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47355982-353567BF-E6D5-458D-A82B-D9F9D0F81CC2
Q47355982-353567BF-E6D5-458D-A82B-D9F9D0F81CC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47355982-353567BF-E6D5-458D-A82B-D9F9D0F81CC2
Emerging drugs for the treatment of gastrointestinal stromal tumour.
P2860
Q47355982-353567BF-E6D5-458D-A82B-D9F9D0F81CC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47355982-353567BF-E6D5-458D-A82B-D9F9D0F81CC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3c134a82960a22d35ef524303fd6e35f869c56c
P2860
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour.